These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36554267)

  • 21. Economic Costs of Cardiovascular Diseases in Poland Estimates for 2015-2017 Years.
    Mela A; Rdzanek E; Poniatowski ŁA; Jaroszyński J; Furtak-Niczyporuk M; Gałązka-Sobotka M; Olejniczak D; Niewada M; Staniszewska A
    Front Pharmacol; 2020; 11():1231. PubMed ID: 33013357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The costs of asthma in Poland in 2012].
    Jahnz-Różyk K; Kucharczyk A; Warchoł M; Radziwilska-Muc A; Władysiuk M; Plisko R
    Pol Merkur Lekarski; 2015 Aug; 39(230):91-5. PubMed ID: 26319382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Economic burden from smoking-related diseases in Thailand.
    Bundhamcharoen K; Aungkulanon S; Makka N; Shibuya K
    Tob Control; 2016 Sep; 25(5):532-7. PubMed ID: 26427527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reimbursed Costs of Management of Uterine Cervical Lesions in Poland--a Descriptive Analysis of Data from the National Health Fund and the Ministry of Health.
    Nowakowski A; Śliwczyński A; Seroczyński P; Cybulski M; Teter Z
    Cent Eur J Public Health; 2016 Jun; 24(2):163-8. PubMed ID: 27178030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Costs of management of patients with coronary artery disease in Poland: the multicenter RECENT study.
    Jaworski R; Jankowska EA; Ponikowski P; Banasiak W
    Pol Arch Med Wewn; 2012; 122(12):599-607. PubMed ID: 23160000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Indirect costs of absenteeism due to rheumatoid arthritis, psoriasis, multiple sclerosis, insulin-dependent diabetes mellitus, and ulcerative colitis in 2012: a study based on real-life data from the Social Insurance Institution in Poland.
    Malinowski KP; Kawalec PP; Moćko P
    Expert Rev Pharmacoecon Outcomes Res; 2016; 16(2):295-303. PubMed ID: 26377953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Social costs of loss in productivity-related absenteeism in Poland.
    Genowska A; Fryc J; Pinkas J; Jamiołkowski J; Szafraniec K; Szpak A; Bojar I
    Int J Occup Med Environ Health; 2017 Oct; 30(6):917-932. PubMed ID: 28584315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Costs of multiple sclerosis - extrapolation of Czech data to Polish patients.
    Szmurło D; Fundament T; Ziobro M; Kruntorádová K; Doležal T; Głogowski C
    Expert Rev Pharmacoecon Outcomes Res; 2014 Jun; 14(3):451-8. PubMed ID: 24702130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct medical and non-medical costs of a one-year care pathway for early operable breast cancer: Results of a French multicenter prospective study.
    Héquet D; Huchon C; Soilly AL; Asselain B; Berseneff H; Trichot C; Combes A; Alves K; Nguyen T; Rouzier R; Baffert S
    PLoS One; 2019; 14(7):e0210917. PubMed ID: 31291250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology and direct costs of atopic dermatitis in Poland based on the National Health Fund register (2008-2017).
    Raciborski F; Jahnz-Rozyk K; Kłak A; Sybilski AJ; Grąbczewska AM; Brzozowska M; Śliwczyñski AM
    Postepy Dermatol Alergol; 2019 Dec; 36(6):727-733. PubMed ID: 31998002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early rheumatoid arthritis 6 years after diagnosis is still associated with high direct costs and increasing loss of productivity: the Swedish TIRA project.
    Hallert E; Husberg M; Kalkan A; Skogh T; Bernfort L
    Scand J Rheumatol; 2014; 43(3):177-83. PubMed ID: 24354438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct healthcare costs and cost-effectiveness of acute coronary syndrome secondary prevention with ticagrelor compared to clopidogrel: economic evaluation from the public payer's perspective in Poland based on the PLATO trial results.
    Pawęska J; Macioch T; Perkowski P; Budaj A; Niewada M
    Kardiol Pol; 2014; 72(9):823-30. PubMed ID: 24846362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Economic Burden of Breast Cancer Survivors in Korea: A Descriptive Study Using a 26-Month Micro-Costing Cohort Approach.
    You CH; Kang S; Kwon YD
    Asian Pac J Cancer Prev; 2019 Jul; 20(7):2131-2137. PubMed ID: 31350976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pancreatic cancer, healthcare cost, and loss of productivity: a register-based approach.
    Tingstedt B; Andersson E; Flink A; Bolin K; Lindgren B; Andersson R
    World J Surg; 2011 Oct; 35(10):2298-305. PubMed ID: 21850604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Survey of economic burden of hepatitis B-related diseases in 12 areas in China].
    Ma QS; Liang S; Xiao HW; Zhang SX; Zhuang GH; Zou YH; Tan HZ; Liu JC; Zhang YH; Xu AQ; Zhang L; Feng XX; Hu DS; Wang FZ; Cui FQ; Liang XF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jul; 38(7):868-876. PubMed ID: 28738457
    [No Abstract]   [Full Text] [Related]  

  • 36. Costs of treatment of adult patients with cystic fibrosis in Poland and internationally.
    Kopciuch D; Zaprutko T; Paczkowska A; Nowakowska E
    Public Health; 2017 Jul; 148():49-55. PubMed ID: 28404533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of Drugs in Clinical Practice and the Associated Cost of Cancer Treatment in Adult Patients with Solid Tumors: A 10-Year Retrospective Cohort Study.
    Carreras MJ; Tomás-Guillén E; Farriols A; Renedo-Miró B; Valdivia C; Vidal J; Saura C; Carles J; Felip E; Gorgas MQ; Tabernero J; Monterde J
    Curr Oncol; 2023 Aug; 30(9):7984-8004. PubMed ID: 37754495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The societal cost of schizophrenia in Sweden.
    Ekman M; Granstrom O; Omerov S; Jacob J; Landen M
    J Ment Health Policy Econ; 2013 Mar; 16(1):13-25. PubMed ID: 23676412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unbalanced Treatment Costs of Breast Cancer in China: Implications From the Direct Costs of Inpatient and Outpatient Care in Liaoning Province.
    Ma Z; Deng G; Meng Z; Ma Y; Wu H
    Int J Health Policy Manag; 2022 Sep; 11(9):1735-1743. PubMed ID: 34380200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cost of lost productivity in pharmacoeconomics analysis. Part I. A systematic review of the literature].
    Wrona W; Hermanowski T; Golicki D; Jakubczyk M; Macioch T; Goszczyńska K; Wójcik R
    Przegl Epidemiol; 2011; 65(1):147-52. PubMed ID: 21735852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.